Rahi D. Patel

FDA investigator

Appears on 2 documents from 2024, mostly at sites in New Jersey. Most often cites control of microbiological contamination (21 CFR 211.113(a)).

2
Documents on file
4.5
Observations per 483
2024
First seen
2024
Most recent

What they cite most

From 9 observations

Activity by year

2024: 2

Where

New Jersey 1 · Pennsylvania 1

Is Rahi D. Patel coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

2 documents, newest first
FirmOpen
483 Cetylite Industries, IncDec 9, 2024 · Pennsauken, New Jersey
483 Boothwyn Pharmacy LLCOct 22, 2024 · Kennett Square, Pennsylvania

About this profile

What does Rahi D. Patel inspect?

Rahi D. Patel appears on 2 documents on file covering 2 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.113(a) (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.100(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Rahi D. Patel is dated Dec 9, 2024.

FDA Investigator Rahi D. Patel: 483s & Inspections · FDA Intel